Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Gauthier

Showing results (311-320 of 370) with videos related to

Pageof 37
Sort By:
Research Square|February 13, 2023
Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer's diseaseTharick Pascoal, Bruna Bellaver, Guilherme Povala, et al.
Molecular Neurodegeneration|January 7, 2024
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathologyJoseph Therriault, Marcel S Woo, Gemma Salvadó, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 20, 2023
Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's diseaseJoseph Therriault, Stijn Servaes, Cécile Tissot, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 17, 2019
The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort StudyHoward Chertkow, Michael Borrie, Victor Whitehead, et al.
Brain : a Journal of Neurology|January 20, 2026
Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy dataLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
Brain Communications|March 14, 2024
Predicting functional decline in aging and Alzheimer's disease with PET-based Braak stagingArthur C Macedo, Joseph Therriault, Cécile Tissot, et al.
Ebiomedicine|February 8, 2022
Comparing tau status determined via plasma pTau181, pTau231 and [<sup>18</sup>F]MK6240 tau-PETCécile Tissot, Joseph Therriault, Peter Kunach, et al.
Neuroimage. Clinical|June 30, 2021
Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's diseaseJennifer Tremblay-Mercier, Cécile Madjar, Samir Das, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMarcel Seungsu Woo, Joseph Therriault, Yi-Ting Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
APOE ɛ4 carriership determines a faster plasma p-tau217 progression in Aβ-positive individualsMarcel S Woo, Arthur C Macedo, Seyyed Ali Hosseini, et al.
Pageof 37

Showing results (311-320 of 370) with videos related to

Sort By:
Pageof 37
Research Square|February 13, 2023
Astrocyte reactivity influences the association of amyloid-β and tau biomarkers in preclinical Alzheimer's diseaseTharick Pascoal, Bruna Bellaver, Guilherme Povala, et al.
Molecular Neurodegeneration|January 7, 2024
Comparison of immunoassay- with mass spectrometry-derived p-tau quantification for the detection of Alzheimer's disease pathologyJoseph Therriault, Marcel S Woo, Gemma Salvadó, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 20, 2023
Equivalence of plasma p-tau217 with cerebrospinal fluid in the diagnosis of Alzheimer's diseaseJoseph Therriault, Stijn Servaes, Cécile Tissot, et al.
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|July 17, 2019
The Comprehensive Assessment of Neurodegeneration and Dementia: Canadian Cohort StudyHoward Chertkow, Michael Borrie, Victor Whitehead, et al.
Brain : a Journal of Neurology|January 20, 2026
Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy dataLydia Trudel, Joseph Therriault, Arthur C Macedo, et al.
Brain Communications|March 14, 2024
Predicting functional decline in aging and Alzheimer's disease with PET-based Braak stagingArthur C Macedo, Joseph Therriault, Cécile Tissot, et al.
Ebiomedicine|February 8, 2022
Comparing tau status determined via plasma pTau181, pTau231 and [<sup>18</sup>F]MK6240 tau-PETCécile Tissot, Joseph Therriault, Peter Kunach, et al.
Neuroimage. Clinical|June 30, 2021
Open science datasets from PREVENT-AD, a longitudinal cohort of pre-symptomatic Alzheimer's diseaseJennifer Tremblay-Mercier, Cécile Madjar, Samir Das, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
BiomarkersMarcel Seungsu Woo, Joseph Therriault, Yi-Ting Wang, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2025
APOE ɛ4 carriership determines a faster plasma p-tau217 progression in Aβ-positive individualsMarcel S Woo, Arthur C Macedo, Seyyed Ali Hosseini, et al.
Pageof 37